Participants 96 143 5
patients with advanced-stage Hodgkin's lymphoma
Participants 731 845 6
The randomized, three-arm trial recruited patients in stages IIB and IIIA with risk factors and stages IIIB and IV
Participants 1294 1378 5
An interim analysis with 505 assessable patients and a median follow-up of 23 months
